Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Allergan, Inc. v. HI-TECH PHARMACAL CO.
Case Number:
6:12-cv-00043
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 14, 2014
Allergan Stymies Generic Glaucoma Med In Patent Trial
Allergan Inc. halted four competing drugmakers' attempts to produce generic versions of its glaucoma drug Lumigan on Monday, when a Texas federal judge ruled that their proposed products would infringe five patents for the brand-name drug.
-
January 27, 2012
Allergan Targets Hi-Tech Over IP For Glaucoma Generic
Allergan Inc. lodged a patent infringement suit in Texas federal court on Friday seeking to stop Hi-Tech Pharmacal Co. Inc. from launching a generic version of Allergan's glaucoma medication Lumigan.